RNU2-30P

Across TCGA pan-cancer cohorts, RNU2-30P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU2-30P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU2-30P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU2-30P expression acts as an unfavorable survival marker, although some lineages such as STAD and BLCA show a favorable association.

STAD, BLCA, and PAAD are the cancer types where RNU2-30P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Median	III,IV	0.627	0.410	.001	80	view →
BLCA	OS	Tertile	All	0.880	0.690	.001	60	view →
PAAD	DFS	Tertile	II,III,IV	0.820	0.328	.016	54	view →
DLBC	OS	Tertile	All	0.526	0.936	.002	18	view →
THYM	DFS	Tertile	III,IV	0.205	0.774	.007	18	view →
READ	DFS	Tertile	III,IV	0.082	0.749	<.001	18	view →
SKCM	DFS	Tertile	All	0.832	0.604	.002	15	view →
KIRC	DFS	Tertile	IV	0.450	0.655	.025	12	view →
LGG	DFS	Tertile	All	0.189	0.430	.002	9	view →
HNSC	OS	Tertile	III,IV	0.338	0.571	.049	6	view →
ESCA	DFS	Median	All	0.427	0.566	.021	4	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU2-30P–STAD (OS)

Open the STAD breakdown →